Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study.
Pylypchuk R, Wells S, Kerr A, Poppe K, Harwood M, Mehta S, Grey C, Wu BP, Selak V, Drury PL, Chan WC, Orr-Walker B, Murphy R, Mann J, Krebs JD, Zhao J, Jackson R.
Pylypchuk R, et al. Among authors: zhao j.
Lancet. 2021 Jun 12;397(10291):2264-2274. doi: 10.1016/S0140-6736(21)00572-9. Epub 2021 Jun 2.
Lancet. 2021.
PMID: 34089656